Skip to main content

Advertisement

Log in

Response to Letter to the Editor ‘Serum irisin concentration in patients with bladder cancer’

  • Urology - Letter to the Editor
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Taken K, Aslan R, Eryilmaz R, Alp HH, Huyut Z, Donmez MI (2022) Serum irisin is a novel biomarker for bladder cancer detection. Int Urol Nephrol 54(1):55–61. https://doi.org/10.1007/s11255-021-03074-4

    Article  CAS  PubMed  Google Scholar 

  2. Kawada T (2022) Serum irisin concentration in patients with bladder cancer. Int Urol Nephrol. https://doi.org/10.1007/s11255-022-03199-0

    Article  PubMed  Google Scholar 

  3. Esawy MM, Abdel-Samd KM (2020) The diagnostic and prognostic roles of serum irisin in bladder cancer. Curr Probl Cancer 44(4):100529. https://doi.org/10.1016/j.currproblcancer.2019.100529

    Article  PubMed  Google Scholar 

  4. Kinn Rod AM, Harkestad N, Jellestad FK, Murison R (2017) Comparison of commercial ELISA assays for quantification of corticosterone in serum. Sci Rep 7(1):6748. https://doi.org/10.1038/s41598-017-06006-4

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kim JS, Galvao DA, Newton RU, Gray E, Taaffe DR (2021) Exercise-induced myokines and their effect on prostate cancer. Nat Rev Urol 18(9):519–542. https://doi.org/10.1038/s41585-021-00476-y

    Article  CAS  PubMed  Google Scholar 

  6. Tsiani E, Tsakiridis N, Kouvelioti R, Jaglanian A, Klentrou P (2021) Current evidence of the role of the myokine irisin in cancer. Cancers (Basel). https://doi.org/10.3390/cancers13112628

    Article  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Muhammet İrfan Dönmez.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Ethical approval

This letter does not contain any studies with human participants or animals performed by the author.

Informed consent

There is no need of informed consent in this letter.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taken, K., Aslan, R., Eryilmaz, R. et al. Response to Letter to the Editor ‘Serum irisin concentration in patients with bladder cancer’. Int Urol Nephrol 54, 1247–1248 (2022). https://doi.org/10.1007/s11255-022-03215-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-022-03215-3

Navigation